BhagwagarZWylezinskaMTaylorM. (2004) Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry161: 368–370.
2.
GodlewskaBRNearJCowenPJ (2015) Neurochemistry of major depression: A study using magnetic resonance spectroscopy. Psychopharmacology (Berl)232: 501–507.
3.
MatthewsPMHoneyGDBullmoreET (2006) Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci7: 732–744.
4.
MuthukumaraswamySDEddenRAJonesDK. (2009) Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc Natl Acad Sci U S A106: 8356–8361.
5.
NearJAnderssonJMaronE. (2013) Unedited in vivo detection and quantification of γ-aminobutyric acid in the occipital cortex using short-TE MRS at 3 T. NMR Biomed26: 1353–1362.
6.
NolteG (2003) The magnetic lead field theorem in the quasi-static approximation and its use for magnetoencephalography forward calculation in realistic volume conductors. Phys Med Biol48: 3637–3652.
7.
NuttDWilsonSLingford-HughesA. (2015) Differences between magnetoencephalographic (MEG) spectral profiles of drugs acting on GABA at synaptic and extrasynaptic sites: A study in healthy volunteers. Neuropharmacology88: 155–163.
8.
OostenveldRFriesPMarisE. (2011) FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data. Comput Intell Neurosci2011: 1–9.
9.
SanacoraGMasonGFRothmanDL. (2002) Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry159: 663–665.
10.
ShawADSaxenaNJacksonLE. (2015) Ketamine amplifies induced gamma frequency oscillations in the human cerebral cortex. Eur Neuropsychopharmacol25: 1136–1146.
11.
TauluSKajolaMSimolaJ (2004) Suppression of interference and artifacts by the Signal Space Separation Method. Brain Topogr16: 269–275.
12.
TaylorMJGodlewskaBRNorburyR. (2012) Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate. Int J Neuropsychopharmacol15: 1541–1546.
13.
TaylorMJMurphySESelvarajS. (2008) Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy. J Psychopharmacol22: 473–476.
14.
TaylorMJNorburyRMurphyS. (2010) Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers. J Psychopharmacol24: 1217–1221.
15.
WoolrichMHuntLGrovesA. (2011) MEG beamforming using Bayesian PCA for adaptive data covariance matrix regularization. Neuroimage57: 1466–1479.
